Eli Lilly said on Saturday its experimental pill orforglipron helped diabetics lose weight and lower their blood sugar, and the company aims to announce in the third quarter trial results for the drug in overweight and obese people without diabetes.
Trending
- Trump’s arch plan and the history of gateways
- Disney to celebrate Winnie the Pooh's 100th birthday with year-long celebration
- Judges uphold decision to drop terrorism case against Kneecap member | UK News
- UK deploys warship in the Mediterranean to protect British bases in Cyprus
- Film show: 'The Bride!' puts Frankenstein in the shade
- Germany, others partially release oil reserves amid Iran war
- How AI can identify breast cancer ‘better’ than a doctor but there’s a catch | Science, Climate & Tech News
- 'Icky and heartbreaking': The $2 per hour worker behind the OnlyFans boom
